Drawing for Serial No. 87668733

USPTO serial 87668733

Serial No. 87668733

Reviewed by CopyMark Law Group

Reg. 6208266Status 700Renewal
Filing date
Status date
Registration date
Dec 1, 2020
Examiner
DICKEY, ERICA
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with Serial No. 87668733?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,446*

Plus Government fees of $1,300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Sam Yip

Sam Yip Idea Intellectual LimitedNo. 49, Bo Ai Road, Zhongzheng District12F-1Taipei, 10044

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the diagnosis, prevention and treatment of neurological diseases and disorders; pharmaceutical preparations for the diagnosis, prevention and treatment of neurodegenerative diseases and disorders; pharmaceutical preparations for the diagnosis, prevention and treatment of peripheral nervous system diseases and disorders; pharmaceutical preparations for the diagnosis, prevention and treatment of cognitive deficiencies and neurodegenerative diseases and for the treatment of brain and spinal cord diseases or degenerative disorders and for improving neurological abilitiesACTIVE—
010Medical apparatus for the treatment of neurodegenerative diseases; medical instruments and articles, namely, analytical apparatus for diagnosis of neurodegenerative diseases; analysis apparatus for medical purposes, namely, non-invasive detection apparatus probes and imaging devices for use in the fields of neurology and neurobiology; diagnostic apparatus for medical purposes, for diagnosing neurodegenerative diseases for use in the fields of neurology and neurobiology; medical diagnostic apparatus for the detection of neurodegenerative diseases and conditions; surgical, medical apparatus and instruments for the prevention, treatment and repair of neurodegenerative diseases and disorders; medical testing apparatus used for the treatment of cognitive deficiencies, neurodegenerative diseases and for the treatment of brain and spinal cord diseases or degenerative disorders and for improving neurological abilitiesACTIVE—
042Pre-clinical and clinical services for pharmaceutical and diagnostic test formulation research, namely, pharmacological studies, toxicokinetic and pharmacokinetic studies, toxicity tests, bioequivalence studies, stability tests, clinical trials, clinical research, medical research in the field of neurodegenerative diseases; conducting clinical trials for diagnostic tests and for pharmaceutical preparations in the field of neurodegenerative diseases; scientific and toxicology research services in the field of neuroscience and neurodegenerative diseases; biopharmaceutical research for development of targeted therapies for use in the treatment of neurodegenerative diseases and disorders; providing medical testing services for research purposes and medical and scientific research information in the fields of degenerative and neurodegenerative diseases; consulting for pharmacology and medical toxicology in the fields of neurodegenerative diseases and disordersACTIVE—
044Providing targeted, individualized treatment regimens, therapies or combination therapy for patients suffering from neurodegenerative diseases and disorders; medical testing for diagnostic or treatment purposes in the field of neurodegenerative diseases and disordersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 1, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Dec 1, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 6, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 6, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 6, 2020EWORTEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED—
Oct 6, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 6, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 6, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Sep 15, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 15, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 26, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 7, 2020PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jul 30, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 23, 2020OTHECASE RETURNED TO EXAMINATION—
Jul 23, 2020IUCNNOTICE OF ALLOWANCE CANCELLED—
Jul 23, 2020EX1GSOU EXTENSION 1 GRANTED—
Jun 11, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 11, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 10, 2020EXT1SOU EXTENSION 1 FILED—
Jun 10, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 9, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 7, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 7, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 7, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 28, 2020ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Apr 28, 2020OTHECASE RETURNED TO EXAMINATION—
Apr 9, 2020ATRQATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED—
Apr 9, 2020PCBGPETITION TO DIRECTOR - CHANGE BASIS - GRANTED—
Apr 2, 2020ERTITEAS RESPONSE TO PETITION INQUIRY LETTER—
Mar 16, 2020PILMPETITION INQUIRY LETTER ISSUED—
Mar 11, 2020APETASSIGNED TO PETITION STAFF—
Mar 10, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 6, 202044EP44(e) PETITION - RECEIVED—
Feb 6, 2020EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Dec 10, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 15, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 15, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 25, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 6, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 6, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Sep 6, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 6, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 6, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 26, 2019GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Aug 26, 2019GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Aug 26, 2019CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Aug 2, 2019NREVNOTICE OF REVIVAL - E-MAILED—
Aug 2, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 2, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 2, 2019ALIEASSIGNED TO LIE—
Aug 2, 2019PGRRPETITION GRANTED - RESPONSE RECEIVED—
Jul 30, 2019APETASSIGNED TO PETITION STAFF—
Jun 8, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 8, 2019PROATEAS PETITION TO REVIVE RECEIVED—
Dec 7, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 7, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 7, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 13, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 12, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 12, 2018ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Sep 5, 2018GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Sep 5, 2018GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 5, 2018CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 15, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 14, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 14, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 14, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 14, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 14, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 12, 2018DOCKASSIGNED TO EXAMINER—
Nov 14, 2017MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Nov 11, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 4, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance